Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information on how we use and manage cookies please take a look at our privacy and cookie policies. Some parts of the site may not work properly if you choose not to accept cookies.

sections
Home > DocuSign > Digitizing the Global Life Sciences Supply Chain:The Critical Role of Digital Transaction Management
 

Digitizing the Global Life Sciences Supply Chain:The Critical Role of Digital Transaction Management

White Paper Published By: DocuSign
DocuSign
Published:  Apr 24, 2018
Type:  White Paper
Length:  12 pages

Life science companies are experiencing a significant transformation in how they bring new products to market.
Organizations must adapt to changes in the marketplace, such as global product commercialization, specialized medicine, new regulations, new payment models, and new technology that are driving more product variety, smaller drug volumes, and shorter product life cycles.
To meet the needs of this new commercial model, life science companies must re-envision the global supply chain and evolve the tools they use to run their business. The supply chain that was designed for launching blockbuster products will not work in the future.
Today, the global supply chain relies on a manual, paper-based process centered on printing documents and sending them via overnight mail, fax, or e-mail with scanned attachments. This time-consuming and costly process is errorprone, tedious for customers and team members, and vulnerable to security and compliance risks.



Tags :